Prozac vs Lexapro

Both are effective for anxiety disorders, but they differ in their FDA approvals. Lexapro (escitalopram) is FDA-approved for generalized anxiety disorder (GAD) alongside MDD, and is frequently chosen for anxiety due to its favorable tolerability profile. Prozac (fluoxetine) is approved for panic disorder and OCD, but its activating properties can initially worsen anxiety symptoms in some people before improving them. Your clinician will match the drug to your specific anxiety type and personal history.

Lexapro is generally regarded as having a cleaner side-effect profile. As the most selective SERT inhibitor among SSRIs, it has fewer off-target receptor effects. Prozac's stimulating nature can cause insomnia, restlessness, or early anxiety in some patients. That said, side-effect experience is highly individual, and some people tolerate Prozac well while finding Lexapro less suitable. A clinician who knows your full health picture is best placed to advise.

Prozac (fluoxetine) has FDA approval for obsessive-compulsive disorder. Lexapro does not carry this indication. If OCD is the primary condition being treated, Prozac and other specifically approved SSRIs — fluvoxamine, sertraline, paroxetine — are the typical first-line pharmacological choices, usually alongside cognitive behavioral therapy with ERP.

Prozac is associated with less long-term weight gain among SSRIs — some patients see modest short-term weight loss. Studies suggest escitalopram may be associated with slightly more weight gain over time, though the difference is generally modest and both are considered relatively weight-neutral compared to older antidepressants. Individual factors, diet, and duration of treatment all play a significant role.

Yes. Prozac (fluoxetine) is FDA-approved for major depressive disorder in children aged 8 and older, and for OCD in children aged 7 and older — making it one of the very few antidepressants with explicit pediatric indications. Lexapro does not share this approval. Prescribing antidepressants to children requires careful clinical judgment, appropriate monitoring, and shared decision-making with the child's caregivers.